REMSleep Financial Statements From 2010 to 2024

RMSL Stock  USD 0.01  0.0001  1.27%   
REMSleep Holdings financial statements provide useful quarterly and yearly information to potential REMSleep Holdings investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on REMSleep Holdings financial statements helps investors assess REMSleep Holdings' valuation, profitability, and current liquidity needs. Key fundamental drivers impacting REMSleep Holdings' valuation are summarized below:
REMSleep Holdings does not now have any trending fundamental ratios for analysis.
Check REMSleep Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among REMSleep Holdings' main balance sheet or income statement drivers, such as , as well as many indicators such as . REMSleep financial statements analysis is a perfect complement when working with REMSleep Holdings Valuation or Volatility modules.
  
This module can also supplement various REMSleep Holdings Technical models . Check out the analysis of REMSleep Holdings Correlation against competitors.

REMSleep Holdings OTC Stock Return On Equity Analysis

REMSleep Holdings' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current REMSleep Holdings Return On Equity

    
  -0.55  
Most of REMSleep Holdings' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, REMSleep Holdings is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, REMSleep Holdings has a Return On Equity of -0.5467. This is 97.72% lower than that of the Health Care Equipment & Supplies sector and 93.74% lower than that of the Health Care industry. The return on equity for all United States stocks is 76.35% higher than that of the company.

REMSleep Holdings Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining REMSleep Holdings's current stock value. Our valuation model uses many indicators to compare REMSleep Holdings value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across REMSleep Holdings competition to find correlations between indicators driving REMSleep Holdings's intrinsic value. More Info.
REMSleep Holdings is rated below average in return on equity category among its peers. It is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the REMSleep Holdings' earnings, one of the primary drivers of an investment's value.

About REMSleep Holdings Financial Statements

REMSleep Holdings investors utilize fundamental indicators, such as revenue or net income, to predict how REMSleep OTC Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. It serves home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. Remsleep Holdings operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 2 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in REMSleep OTC Stock

REMSleep Holdings financial ratios help investors to determine whether REMSleep OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in REMSleep with respect to the benefits of owning REMSleep Holdings security.